netFormulary NHS
Bedfordshire and Luton Joint Formulary
Bedford Hospital NHS Trust
Bedfordshire CCG
Luton & Dunstable University Hospital NHS Foundation Trust
Luton CCG
 Search
 Results

Looking for Aflibercept found 8 matches

Formulary BNF Category
  Aflibercept 40mg/1mL  (Eylea)
(Intravitreal Injection )
Subfoveal choroidal neovascularisation - 11.08.02
 
Non Formulary BNF Category
  Cytotoxic Drug Aflibercept  (Zaltrap) Other antineoplastic drugs - 08.01.05


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA294: Macular degeneration (wet age-related) - aflibercept (11.08.02)
link in drug section NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (11.08.02)
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01.05)
link in drug section NICE TA346: Aflibercept for treating diabetic macular oedema (08.01.05)
link in drug section NICE TA346: Aflibercept for treating diabetic macular oedema (11.08.02)
link in drug section NICE TA486: Aflibercept for treating choroidal neovascularisation (11.08.02)


 

netFormulary